Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases.

about

Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases.

Item

http://www.wikidata.org/entity/Q54958903

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@en

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@nl

type

Item

label

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@en

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@nl

prefLabel

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@en

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@nl

P1476

Pharmacotherapeutic considerat ...... ients with malignant diseases.

@en

P2093

Marija Darkovska-Serafimovska

http://www.w3.org/2001/XMLSchema#string

Sasho Stefanoski

http://www.w3.org/2001/XMLSchema#string

Tijana Serafimovska

http://www.w3.org/2001/XMLSchema#string

Trajan Balkanov

http://www.w3.org/2001/XMLSchema#string

Zlatko Keskovski

http://www.w3.org/2001/XMLSchema#string

Zorica Arsova-Sarafinovska

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

Cannabinoid receptors and pain

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Molecular characterization of a peripheral receptor for cannabinoids

Cannabinoids in medicine: A review of their therapeutic potential

Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Cannabis and the brain.

Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial.

P304

837-842

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JPR.S160556

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29719417

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids

P932

5922297

http://www.w3.org/2001/XMLSchema#string